XERIS BIOPHARMA HOLDINGS, INC. Peer Group Total Shareholder Rtn Amt
XERIS BIOPHARMA HOLDINGS, INC. (XERS) reported Peer Group Total Shareholder Rtn Amt of $124.75 for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-23.
Financial Statements › Notes
ecd:PeerGroupTotalShareholderRtnAmt · last filed 2026-04-23
| Period end | Peer Group Total Shareholder Rtn Amt 12 month |
|---|---|
| 2025-12-31 | $124.75 DEF 14A · filed 2026-04-23 |
| 2024-12-31 | $93.49 DEF 14A · filed 2026-04-23 |
| 2023-12-31 | $94.03 DEF 14A · filed 2026-04-23 |
| 2022-12-31 | $89.90 DEF 14A · filed 2026-04-23 |
| 2021-12-31 | $100.02 DEF 14A · filed 2026-04-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |